• Western blot analysis of lysate from mouse brain, using Smad6 antibody.
  • Immunohistochemistry analysis of Smad6 antibody in paraffin-embedded human lung carcinoma tissue.

Anti-SMAD6 antibody (323-372 aa) (STJ95703)

SKU:
STJ95703

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Mothers against decapentaplegic homolog 6 (323-372 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:40000
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: SMAD6
Gene ID: 4091
Uniprot ID: SMAD6_HUMAN
Immunogen Region: 323-372 aa
Specificity: Smad6 Polyclonal Antibody detects endogenous levels of Smad6 protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human Smad6 at the amino acid range 323-372
Post Translational Modifications Phosphorylated by BMP type 1 receptor kinase and by PRKX. Monoubiquitinated at Lys-173 by the E2/E3 hybrid ubiquitin-protein ligase UBE2O, leading to reduced binding affinity for the activated BMP type I receptor ACVR1/ALK2, thereby enhancing BMP7 and regulating adipocyte differentiation. Ubiquitinated by WWP1. Ubiquitinated by ARK2C, promoting proteasomal degradation, leading to enhance the BMP-Smad signaling. Arginine methylation by PRMT1, which is recruited by BMPR2, initiates BMP-Induced signaling and induces dissociation from the BMPR1B receptor at the cell surface leading to derepress downstream Smad1/Smad5 signaling.
Function Transforming growth factor-beta superfamily receptors signaling occurs through the Smad family of intracellular mediators. SMAD6 is an inhibitory Smad (i-Smad) that negatively regulates signaling downstream of type I transforming growth factor-beta. Acts as a mediator of TGF-beta and BMP anti-inflammatory activities. Suppresses IL1R-TLR signaling through its direct interaction with PEL1, preventing NF-kappa-B activation, nuclear transport and NF-kappa-B-mediated expression of pro-inflammatory genes. Blocks the BMP-SMAD1 signaling pathway by competing with SMAD4 for receptor-activated SMAD1-binding. Binds to regulatory elements in target promoter regions.
Protein Name Mothers Against Decapentaplegic Homolog 6
Mad Homolog 6
Mothers Against Dpp Homolog 6
Smad Family Member 6
Smad 6
Smad6
Hsmad6
Database Links Reactome: R-HSA-201451
Reactome: R-HSA-8941326
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Mothers Against Decapentaplegic Homolog 6 antibody
Anti-Mad Homolog 6 antibody
Anti-Mothers Against Dpp Homolog 6 antibody
Anti-Smad Family Member 6 antibody
Anti-Smad 6 antibody
Anti-Smad6 antibody
Anti-Hsmad6 antibody
Anti-SMAD6 antibody
Anti-MADH6 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance